SRPT Q1 2022 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$211M+43.5% YoY

Gross Profit

$179M85.1% margin

Operating Income

-$87M-41.2% margin

Net Income

-$105M-49.8% margin

EPS (Diluted)

$-1.20

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

-$101M

Free Cash Flow

-$107M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$2.2B

Stockholders' Equity

$857M

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$211M	$147M	+43.5%
Gross Profit	$179M	$125M	+44.0%
Operating Income	-$87M	-$152M	+42.8%
Net Income	-$105M	-$167M	+37.2%